PrEPaRe (PrEP and Resistance) is a new study within the RESPOND network. The study is a pilot project designed to investigate PrEP use in people newly diagnosed with HIV. We aim at collecting information on people newly diagnosed with HIV who have taken PrEP prior to being diagnosed with HIV.

The study started in 2021 and enrolment is ongoing. PrEPaRe aims is taking place in 20 countries and currently, 72 sites have shown interest in participating.

Main Funding Body